NEW YORK STATE COMMON RETIREMENT FUND - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,003,000
-55.2%
49,739
-17.1%
0.00%
-50.0%
Q2 2021$2,240,000
+47.3%
60,024
+0.9%
0.00%0.0%
Q1 2021$1,521,000
+16.0%
59,5000.0%0.00%
+100.0%
Q4 2020$1,311,000
+22.5%
59,5000.0%0.00%0.0%
Q3 2020$1,070,000
-29.2%
59,5000.0%0.00%
-50.0%
Q2 2020$1,511,000
+76.9%
59,500
+28.0%
0.00%
+100.0%
Q1 2020$854,000
-16.6%
46,5000.0%0.00%0.0%
Q4 2019$1,024,000
+32.3%
46,500
-13.7%
0.00%0.0%
Q3 2019$774,000
-8.8%
53,9000.0%0.00%0.0%
Q2 2019$849,000
+7.5%
53,9000.0%0.00%0.0%
Q1 2019$790,000
+74.4%
53,900
+27.1%
0.00%0.0%
Q4 2018$453,000
-39.9%
42,400
-14.2%
0.00%0.0%
Q3 2018$754,000
+24.6%
49,4000.0%0.00%0.0%
Q2 2018$605,000
+717.6%
49,400
+258.0%
0.00%
Q1 2016$74,000
-54.9%
13,8000.0%0.00%
Q4 2015$164,000
+45.1%
13,8000.0%0.00%
Q3 2015$113,000
-27.1%
13,800
+24.4%
0.00%
Q2 2015$155,00011,0960.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,456,595$49,525,0009.00%
COMMODORE CAPITAL LP 1,292,251$26,052,0006.87%
Bain Capital Life Sciences Investors, LLC 3,080,237$62,098,0003.85%
GREAT POINT PARTNERS LLC 799,999$16,128,0003.76%
DAFNA Capital Management LLC 587,456$11,843,0003.14%
Eagle Health Investments LP 406,525$8,196,0002.60%
RTW INVESTMENTS, LP 7,582,396$152,861,0002.30%
Parkman Healthcare Partners LLC 209,686$4,227,0001.07%
Palo Alto Investors LP 855,713$17,251,0001.04%
Lombard Odier Asset Management (Switzerland) SA 701,305$14,138,0000.88%
View complete list of DICERNA PHARMACEUTICALS INC shareholders